NEUROLOGICAL COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA IN ADULTS


Cite item

Full Text

Abstract

This is a review of neurological complications of chronic lymphocytic leukemia in adults. There was given their detailed clinical description as well as the main principles of their diagnosis and management.

About the authors

Dinara R Teregulova

City Clinical Hospital №5

Email: dinamail@mail.ru
Ufa, 450005, Parkhomenko str., 93

Bulat A Bakirov

Clinic of Bashkortostan State Medical University

Email: bakirovb@gmail.com
Ufa, Shafiev str., 2

Denis E Baikov

Clinic of Bashkortostan State Medical University

Ufa, Shafiev str., 2

Leila R Akhmadeeva

Bashkortostan State Medical University

Email: la@ufaneuro.org
Department of Neurology, Neurosurgery and medical genetics Ufa, Lenina str., 3

References

  1. Доронин В.А., Худолеева О.А., Пашин Л.Е. и др. Поражение центральной нервной системы при В-клеточном хроническом лимфолейкозе (клинический случай и обзор литературы) // Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2008. Т.1, № 2. С. 164-167.
  2. Избранные лекции по внутренним болезням. Болезни органов пищеварения, почек, крови и соединительной ткани [под ред. Мирсаевой Г.Х., Мавзютовой Г.А.]. Уфа: ГУП РБ Уфимский полиграфический комбинат, 2013. С. 254-260.
  3. Королёва Н.В., А.Б. Карпов, P.M. Тахауов и др. Оценка распространённости гемобластозов среди детского населения г. Северска // Бюлл. сибирской медицины. 2007. №2. С. 103-109.
  4. Чигринова Е. В., Бялик Т. Е., Андреева Л. Ю. и др. Хронический В-клеточный лимфолейкоз у лиц моложе 30 лет: агрессивное клиническое течение и рефрактерность к химиотерапии // Гематология и трансфузиология. 2004. №3. С. 11-15.
  5. Abedalthagafi M., Rushing E.J., Garvin D. et al. Asymptomatic diffuse “encephalitic”cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literature // Int. J. Clin. Exp. Pathol. 2009. Vol. 3. P. 106-9.
  6. Altaf A.R., Hansen P.B. Life-threatening hyponatremia provoked by alternative treatment. An occurrence in a patient with chronic lymphocytic leukemia with no indication for treatment // Ugeskr Laeger. 2007. Vol. 169. P. 4367-4368.
  7. Amend K.L., Turnbull B., Foskett N. et al. Incidence of progressive multifocal leukoencephalopathy in patients without HIV // Neurology. 2010. Vol. 75. P. 1326-1332.
  8. Anaissie E.J., Kontoyiannis D.P., O’Brien S. et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine // Ann. Intern. Med. 1998. Vol.129. P. 559-566.
  9. Bacchu S., Fegan C., Neal J. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine // Br. J. Haematol. 2007. Vol. 139. P. 349.
  10. Barcos M., Lane W, Gomez GA, et al. An autopsy study of 1206 acute and chronic leukemias (1958 to 1982) // Cancer.1987. Vol. 60. P. 827-37.
  11. Blaes F., Tschernatsch M. Paraneoplastic neurological disorders // Expert Rev. Neurother. 2010. Vol. 10. P. 1559-1568.
  12. Bojsen-Moller M., Nielsen J.L. CNS involvement in leukaemia. An autopsy study of 100 consecutive patients // Acta. Pathol. Microbiol. Immunol. Scand. 1983. Vol. 91. P. 209-216.
  13. Bosch E.P., Habermann T.M., Tefferi A. Peripheral neuropathy associated with lymphoma, leukemia and myeloproliferative disorders. In: Dyck P.J., Thomas P.K., eds. Peripheral Neuropathy. 4th edition. Philadelphia,Elsevier Saunders.2005. P. 2489-2503.
  14. Bower J.H., Hammack J.E. Shannon K. et al. The neurologic complications of B-cell chronic lymphocytic leukemia // Neurology. 1997. Vol. 48. P. 407-412.
  15. Bruce D.R., Rane N.S., Schuh A. Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia // Br. J. Haematol. 2014. Vol. 167(4). P. 570-571.
  16. Chamberlain M.C. Leukemia and the nervous system // Current Oncology Reports. 2005. Vol. 7, I.1. P. 66-73.
  17. Cheson B.D., Vena D.A., Foss F.M.,et al. Neurotoxicity of purine analogs: a review // J. Clin. Oncol. 1994. Vol. 12. P. 2216-2228.
  18. Counsel P., Khangure M. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings // Clin. Radiol. 2007. Vol.62. P. 172-176.
  19. Cramer S.C, Glaspy J.A, Efird J.T. et al. Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study // Neurology. 1996. Vol. 46. P. 19-25.
  20. Creange A., Theodorou I., Sabourin J.C. et al. Inflammatory neuromuscular disorders associated with chronic lymphoid leukemia: evidence for clonal B cells within muscle and nerve // J. Neurol. Sci. 1996. Vol. 137. P. 35-41.
  21. De Lima M., O’Brien S., Lerner S. et al. Chronic lymphocytic leukemia in the young patient // Semin. Oncol. 1998. Vol. 25(1). P. 107-116.
  22. De Vito N., Mui K., Jassam Y. et al. Small lymphocytic lymphoma presenting as a paraneoplastic syndrome with acute central nervous system demyelination // Clinical Lymphoma, Myeloma & Leukemia. 2014. Vol. 14(4). P. 131-135.
  23. Di Pauli F., Berger T., Walder A. et al. Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature // J. Clin. Virol. 2014. Vol. 60(4). P. 427-427.
  24. D’Souza A, Wilson J, Mukherjee S, et al. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature // Clin Lymphoma Myeloma Leuk. 2010. Vol. 10. P. 1-9.
  25. D’Souza S.L., Santiago F., D’Moura Ribeiro-Carvalho M. Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature // BMC Research Notes. 2014. Vol. 7. P. 645.
  26. Elliott M.A., Letendre L., Chin-Yang L. et al. Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine // Br. J. Haematol. 1999. Vol. 104. P. 689-694.
  27. Eloraby A.M. L-asparaginase therapy with concomitant cranial venous thrombosis: can MRI help avoid stroke // J. Egypt. Natl. Cancer Inst. 2009. Vol. 21. P. 43-50.
  28. García-Suárez J., de Miguel D., Krsnik I. et al. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies // Am. J. Hematol. 2005. Vol.80. P. 271-281.
  29. Getaz E.P., Miller G.J. Spinal cord involvement in chronic lymphocytic leukemia // Cancer.1979. Vol. 43. P.1858-1861.
  30. Glantz M.J., Cole B.F, Glantz L.K. et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results // Cancer. 1998. Vol. 82. P. 733-739.
  31. Gonzalez H., Bolgert F., Camporo P. et al. Progressive multifocal leukoencephalitis (PML) in three patients treated with standard dose fludarabine (FAMP) // Hemato. Cell Ther.1999. Vol. 41. P. 183-186.
  32. Graus F., Delattre J.Y., Antoine J.C. et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes // J. Neurol. Neurosurg. Psychiatry. 2004. Vol. 75. P.1135-1140.
  33. Hafner J., Kumar K., Mulligan S. et al. Multifocal central nervous system demyelination and Lhermitte’s phenomenon secondary to combination chemotherapy for chronic lymphocytic leukaemia // J. Neurol. Sci. 2014. Vol. 338 (1-2). P. 218-219.
  34. Hagberg H., Lannemyr O., Acosta S. et al. Successful treatment of syndrome of inappropriate antidiuretic secretion (SIADH) in 2 patients with CNS involvement of chronic lymphocytic leukaemia // Eur. J. Haematol. 1997. Vol. 58. P. 207-208.
  35. Haider I., Cahill M. Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy // Hematology. 2004. Vol. 9. P.409-211.
  36. Hamblin T.J. Autoimmune complications of chronic lymphocytic leukemia // Semin. Oncol. 2006. Vol. 33. P. 230-239.
  37. Hasselbach H.C., Fickenscher H., Nölle B.et al. Atypical ocular toxoplasmosis with concomitant ocular reactivation of varicella-zoster virus and cytomegalovirus in an immunocompromised host // Klin. Monbl. Augenheilkd. 2008. Vol. 225. P. 236-239.
  38. Heidys G., De la Fuente A., Ona R. Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia // Exp. Hematol. Oncol. 2015. Vol. 4. P. 8.
  39. Holtzer-Goor K.M., Schaafsma M.R., Joosten R. Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study // Qual Life Res. 24.07. 2015. URL: http://link.springer.com/article/10.1007%2Fs11136-015-1039-y.
  40. Holzapfel C., Kellinghaus C., Lüttmann R. et al. Progressive multifocal leukoencephalopathy (PML) in chronic lymphatic leukemia (CLL). Review of the literature and case report // Nervenarzt. 2002. Vol. 73. P. 543-547.
  41. Honnorat J. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes // Acta. Neurol. Scand. Suppl. 2006. Vol. 183. P. 64-68.
  42. Hughes B.A., Kimmel D.W., Aksamit A.J. Herpes zoster-associated meningoencephalitis in patients with systemic cancer // Mayo. Clin. Proc. 1993. Vol. 68. P. 652-655.
  43. Kang J.H., Sheu J.J., Lin H.C. Increased risk of Guillain-Barré syndrome following recent herpes zoster: a population-based study across Taiwan // Clin. Infect. Dis. 2010. Vol. 51. P. 525-530.
  44. Kelly K., Lynch K., Farrell M. et al. Intracranial small lymphocytic lymphoma // Br. J. Haematol. 2008. Vol. 141. P.411.
  45. Lange C.P., Brouwer R.E., Brooimans R. et al. Leptomeningeal disease in chronic lymphocytic leukemia // Clin. Neurol. Neurosurg. 2007. Vol. 109. P. 896-901.
  46. Laugen R.H., Carey R.M., Wills M.R.et al. Hypercalcemia associated with chronic lymphocytic leukemia // Arch. Intern. Med. 1979. Vol. 139. P. 1307-1309.
  47. Lee S.H., Hur J., Kim Y.J. et al. Additional value of dual-energy CT to differentiate between benign and malignant mediastinal tumors: an initial experience // Eur. J. Radiol. 2013. Vol. 82. P. 2043-2049.
  48. Lopes Da Silva R. Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia // Clinical Lymphoma, Myeloma & Leukemia. 2012. Vol. 12, № 3. P. 164-79.
  49. Lustman F., Flament-Durant J., Colle H. et al. Paraplegia due to epidural infiltration in a case of chronic lymphocytic leukemia // J. Neurooncol. 1988. Vol.6. P. 59-60.
  50. Majumdar G. Chronic lymphocytic leukaemia with cerebral infiltration // Leuk. Lymphoma.1998. Vol. 28. P. 603-605.
  51. Marmont A.M. Leukemic meningitis in B-cell chronic lymphocytic leukemia: resolution following intrathecal methotrexate // Blood. 2000. Vol. 96. P. 776-777.
  52. Messori A., Fadda V., Maratea D. et al. First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis // Ann. Hematol. 2015. Vol. 94(6). P. 1003-1009.
  53. Michalevicz R., Burstein A., Razon N. et al. Spinal epidural compression in chronic lymphocytic leukemia // Cancer. 1989. Vol. 64. P. 1961-1964.
  54. Morrison C., Shah S., Flinn I.W. Leptomeningeal involvement in chronic lymphocytic leukemia // Cancer Pract. 1998. Vol. 6, № 4. P. 223-228.
  55. Nimubona S., Bernard M., Morice P. et al. Complications of malignancy: case 3. Chronic lymphocytic leukemia presenting with panhypopituitarism // J. Clin. Oncol. 2004. Vol. 22. P. 274-276.
  56. Nowakowski G.S., Call T.G., Morice W.G. et al. Clinical significance of monoclonal B-cells in cerebrospinal fluid // Cytometry B Clin. Cytom. 2005. Vol. 63. P. 23-27.
  57. Reisfeld-Zadok S., Elis A., Szyper-Kravitz M. et al. Cryptococcal meningitis in chronic lymphocytic leukemia patients // Isr. Med. Assoc J. 2009. Vol. 11. P. 437-439.
  58. Reske-Nielsen E., Petersen J.H., Sogaard H. et al. Leukaemia of the central nervous system // Lancet. 1974. Vol. 1. P. 211-212.
  59. Rey J., Attarian S., Disdier P. et al. Myasthenia gravis and chronic lymphocytic leukemia: a lucky association // Rev. Med. Interne. 2001. Vol. 22. P. 1129-1130.
  60. Rye A.D., Stitson R.N., Dyer M.J. Pituitary infiltration in B-cell chronic lymphocytic Leukaemia // Br. J. Haematol. 2001. Vol. 115. P. 718.
  61. Salloum E., Khan K.K., Cooper D.L. Chlorambucil-induced seizures // Cancer. 1997. Vol. 79. P. 1009-1013.
  62. Sengupta S., Benkers T., Blitstein M. et al. Posterior Reversible Encephalopathy Syndrome (PRES) Complicating Newly-Diagnosed Diffuse Large B-Cell Lymphoma // Clin. Lymphoma Myeloma Leuk. 2014. Vol. 14, I.4. P.11-113.
  63. Singhal R.L., Corman L.C. Subacute herpes simplex virus type 1 encephalitis as an initial presentation of chronic lymphocytic leukemia and multiple sclerosis: a case report // J. Med. Case Reports. 2011. Vol. 5. P. 59.
  64. Stagg M.P., Gumbart C.H. Chronic lymphocytic leukemic meningitis as a cause of the syndrome of inappropriate secretion of antidiuretic hormone // Cancer. 1987. Vol. 60. P. 191-192.
  65. Stübgen J.P. Lymphoma-associated dysimmune polyneuropathies // J. Neurol. Sci. 2015. Vol. 355(1-2). P. 25-36.
  66. Swerdlow S.H et al. WHO classification of tumours of haematopoietic and lymphoid tissues: International Agency for Research on Cancer. Lyon, 2008.
  67. Travis L.B., Curtis R.E., Hankey B.F. et al. Second cancers in patients with chronic lymphocytic leukemia // J. Natl. Cancer Inst. 1992. Vol. 84. P. 1422-1427.

Copyright (c) 2015 Teregulova D.R., Bakirov B.A., Baikov D.E., Akhmadeeva L.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies